In 2008 Dr. Nousheen Zaidi received her doctoral degree in biochemistry from Eberhard Karls University, Tubingen, Germany. After completing her PhD training she moved to New York City and started her post-doctoral research at the Albert Einstein College of Medicine. There she worked from 2009 to 2010. In early 2011, Dr. Zaidi joined the Drug Discovery Group, Oncology, Johnson and Johnson (J&J), Belgium as a postdoctoral research associate. At J&J she worked on a project related to tumor metabolism. In late 2012, Dr. Zaidi moved to Lahore to join the faculty of the Department of Microbiology and Molecular Genetics, Punjab University. Her lab continues to focus on tumor metabolism that has emerged as one of the most exciting and dynamic fields of research for the academic and industrial scientists working in cancer therapeutics. Dr. Zaidi is mainly interested in studying the role of de novo lipid synthesis pathways in cancer cell development, progression and survival. To study the relative importance of dietary and endogenously synthesized lipids for cancer cell progression is one of the key aims of her ongoing/future projects. Currently, she is also a visiting scientist at Bundesanstalt für Materialforschung und -prüfung (BAM) (2017-2019) (Supported by Georg Forster Research Fellowship for Experienced Researchers by the Humboldt Foundation, 2017- 19).